TRAW Traws Pharma Inc Net earnings per share growth forecast for next year

Public company logo of trawspharma.com (TRAW)

Traws Pharma, Inc. (TRAW) develops convenient oral treatments for respiratory viruses, replacing complex injections with tablets. A robust instrumentation base and contract lines ensure an uninterrupted clinical trial cycle. A strategic alliance with the NIH accelerates the discovery of new molecules and the pursuit of investment. The historical trend of the n+1 profit forecast confirms the asset's potential, and the value has stabilized at -2.90.

TRAW - Traws Therapeutics Projected earnings per share increase next year over the range 04/04/2024 - 11/15/2026

Analytical breakdowns and data insights for company Traws Pharma, Inc. (TRAW)

- market capitalization data:
Comprehensive company analysis:TRAW, Traws Therapeutics
Finished products of Traws Therapeutics

Traws Pharma, Inc. (TRAW) development of unique protease inhibitors ensures pricing power, which reflects the current trajectory of next year's EPS forecasts on the GURU.Markets platform. This indicator measures the expected percentage difference between future and current earnings per share, determining the pace of business scaling. Positive dynamics confirm the company's ability to convert innovation into real cash flow even amidst a high cost of capital.

Competitor analysis

Expected earnings per share growth for next year GILD|Earnings growth forecast for next year Cidara Therapeutics, Inc.|Net earnings per share growth forecast for next year Novavax Inc (NVAX)|Consensus forecast of earnings per share growth for next year CureVac|Valneva Pharma - Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Vir Corp (VIR)|siga.com - Earnings growth forecast for next year|Expected net earnings per share growth next year emergentbiosolutions.com|AVIR: Earnings growth forecast for next year|IVVD (Invivyd Inc) - Net earnings per share growth forecast for next year|Net earnings per share growth forecast for next year Enanta Pharmaceuticals|Inovio Pharma (INO) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year HLVX|KLRS (Kalaris Therapeutics Inc) - Expected earnings per share trend next year|Earnings growth forecast for next year DYAI (Dyadic International)|Consensus forecast of earnings per share growth for next year NanoViricides, Inc. (NNVC)|TLPH - Net earnings per share growth forecast for next year|Cocrystal - Projected earnings per share increase next year|DWTX (Virios Therapeutics) - Expected earnings per share growth for next year|Projected earnings per share growth rate for next year QLGN|ALVR (AlloVir) - Earnings growth forecast for next year|vbivaccines.com (VBIV) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year VIRI|Expected earnings per share growth for next year Vaxart Corp VXRT